Search
News
Cartesian Therapeutics Q2 2026 earnings: R&D spending rises as Phase 3 advances
Cartesian Therapeutics reported no revenue for Q2 2026, versus $0.3 million a year earlier, while diluted EPS eased to $0.46 from $0.50. R&D expense climbed to $20.4 million as Phase 3 AURORA advanced, widening operating loss to $29.2 million. Net income of $15.8 million was supported by a $49.2 million fair-value gain on contingent value rights. Cash, cash equivalents and restricted cash totaled $149.3 million at June 30, and the company expects resources to support operations into 2028, with AURORA data expected in Q1 2027.
TradingKey
Thu, Aug 6
Iovance Q2 2026 Earnings: Amtagvi Drives 66% Revenue Growth and a Narrower Loss
Iovance Biotherapeutics’ second-quarter 2026 revenue rose 66% year over year to $99.3 million, led by approximately $91 million of U.S. Amtagvi sales. Gross margin reached 56%, excluding depreciation and amortization, while net loss narrowed to $47.3 million from $111.7 million and diluted EPS improved to -$0.11 from -$0.33. Lower cost of sales and R&D spending helped reduce the operating loss. Iovance ended June with about $304 million in cash resources and is reviewing its existing $350 million to $370 million full-year revenue guidance.
TradingKey
Thu, Aug 6
Ocugen Q2 2026 earnings: Financing boosts cash while net loss widens
Ocugen’s second-quarter 2026 revenue rose 8.4% to $1.49 million, while net loss widened to $24.9 million and diluted loss per share increased to $0.07 from $0.05. Operating expenses climbed 18.2% as research and development spending increased, and financing-related costs further pressured the bottom line. Cash, cash equivalents, and restricted cash reached $100.4 million after a $130.0 million convertible-note offering. Ocugen said the financing extends its runway into 2028 as OCU400, OCU410, and OCU410ST approach major clinical milestones.
TradingKey
Thu, Aug 6
Tarsus Q2 2026 earnings: XDEMVY sales rise 69% as spending limits loss improvement
Tarsus Pharmaceuticals’ Q2 2026 results were led by XDEMVY net product sales of $173.9 million, up more than 69% year over year. Basic and diluted net loss per share narrowed to $0.43 from $0.48, but expanded commercialization and clinical-development spending kept the company unprofitable despite higher product volume and improved gross-to-net discounts. Tarsus raised full-year 2026 XDEMVY net product sales guidance to $685 million-$705 million as prescription depth increased, while pipeline expansion and continued investment remain central issues for investors to monitor.
TradingKey
Thu, Aug 6
Lifetime Brands Q2 2026 Earnings: Tariff Refund Drives the Profit Rebound
Lifetime Brands’ Q2 2026 net sales rose 7.4% to $141.6 million, while diluted EPS swung to $0.87 from a $1.83 loss. A $40.1 million tariff refund lifted gross margin to 65.9% and was the main driver of the reported profit rebound; excluding that benefit, gross margin was approximately 37.5%. U.S. and International sales both grew, and six-month operating cash flow reached $46.0 million. The company kept full-year sales guidance at $650 million to $700 million but raised profit and adjusted EBITDA guidance to incorporate the tariff refund.
TradingKey
Thu, Aug 6
Appian Q2 2026 earnings: Revenue rises 19% as operating loss narrows
Appian’s Q2 2026 revenue rose 19% year over year to $203.3 million, led by cloud subscription revenue of $131.7 million, up 23%. The GAAP operating loss narrowed to $5.4 million from $11.0 million as revenue grew faster than operating expenses, and quarterly operating cash flow turned positive. However, GAAP net loss widened because the prior-year period included substantial other income tied largely to foreign-exchange effects. The quarter showed better operating leverage while the gap between GAAP and non-GAAP profitability remained important.
TradingKey
Thu, Aug 6
Via Q2 FY2026 earnings: Revenue rises 27% as adjusted loss narrows
Via Transportation’s fiscal Q2 2026 revenue rose 27% year over year to $135.7 million, while GAAP diluted EPS improved to -$0.24 from -$1.65. Gross profit increased 33% and adjusted EBITDA loss narrowed to $3.4 million from $9.1 million, although the GAAP operating loss widened as operating expenses and stock-based compensation increased. Customer count reached 847, and U.S. revenue grew 35%. Via guided to $550 million-$553 million in FY2026 platform revenue and maintained a target of positive adjusted EBITDA in Q4.
TradingKey
Thu, Aug 6
Nexstar Q2 2026 Earnings: TEGNA and Political Ads Drive Record Revenue
Nexstar Media Group’s Q2 2026 revenue rose 62.2% to a record $1.993 billion, helped by $697 million from TEGNA and higher political advertising. Net income increased 24.2% to $113 million, while diluted EPS rose to $3.61 from $3.06. Adjusted EBITDA advanced 62.7% to $633 million, but GAAP net margin fell to 5.7% as transaction-related costs and higher interest expense weighed on profitability. Operating cash flow reached $298 million, supporting $409 million of debt repayment and $57 million of dividends during the quarter.
TradingKey
Thu, Aug 6
ConocoPhillips Q2 2026 earnings: Higher prices lift EPS despite lower production
ConocoPhillips’ Q2 2026 net income rose to $3.9 billion, or $3.23 per share, from $2.0 billion and $1.56 a year earlier. Adjusted EPS reached $3.24, while cash provided by operating activities was $7.4 billion. A 36% increase in the average realized price to $62.33 per BOE drove the earnings improvement even as reported production fell to 2.248 MMBOED. The company raised quarterly shareholder distributions to $3.0 billion and guided Q3 production to 2.29–2.32 MMBOED while reaffirming all full-year guidance items.
TradingKey
Thu, Aug 6
D-Wave Q2 2026 earnings: Flat revenue and a wider adjusted EBITDA loss
D-Wave Quantum’s Q2 2026 revenue was $3.1 million, essentially flat year over year, while its GAAP loss per share narrowed to $0.13 from $0.55. The improvement mainly reflected a $142.0 million reduction in non-cash warrant-liability remeasurement charges, while adjusted EBITDA loss widened 85% to $37.1 million as product-development and go-to-market spending increased. Quarterly bookings rose 59% to $2.1 million, and first-half remaining performance obligations reached $40.7 million, highlighting stronger contracted demand but leaving revenue conversion and expense discipline as the main issues to monitor.
TradingKey
Thu, Aug 6
Unity Q2 2026 Earnings: Vector-Led Grow Revenue Lifts Revenue 24%
Unity Software’s Q2 2026 revenue rose 24% year over year to $546.5 million, led by 63% growth in Strategic Grow revenue. GAAP net loss narrowed to $22.7 million, while adjusted EBITDA increased to $160.2 million and free cash flow reached $202.0 million. Strategic revenue grew 38% even as non-strategic revenue fell 33%, reflecting the ironSource Ads sunset and Supersonic transition. Q3 guidance calls for $540 million to $550 million of strategic revenue and $185 million to $190 million of adjusted EBITDA.
TradingKey
Thu, Aug 6
TIC Solutions Q2 2026 results: NV5 drives revenue as GAAP loss widens
TIC Solutions’ second-quarter 2026 revenue rose 86% to $584.3 million, largely because the reported results now include NV5, while combined revenue growth was 3.3% and organic growth was 2.5%. The company posted a $13.3 million net loss and a diluted loss of $0.06 per share, compared with a $0.2 million loss a year earlier, while adjusted EBITDA increased 74% to $94.8 million. Consulting & Engineering and Geospatial backlog reached a record $1.18 billion, and TIC reaffirmed its full-year revenue and adjusted EBITDA guidance.
TradingKey
Thu, Aug 6
Real Brokerage Q2 2026 earnings: Revenue grew 30% as acquisition costs drove a GAAP loss
Real Brokerage’s Q2 2026 revenue rose 30% to $700.6 million as closed transactions increased 27% and agent count grew 26%. Gross profit climbed 22% to $58.3 million, but $11.6 million of RE/MAX acquisition costs contributed to an $8.0 million GAAP net loss and diluted loss per share of $0.03. Adjusted EBITDA increased 38% to $27.6 million, while operating cash flow reached $47.2 million. The company ended June with $86.6 million of unrestricted cash and short-term investments and no debt as it worked toward the pending acquisition.
TradingKey
Thu, Aug 6
Genius Sports Q2 2026 earnings: Revenue rises 65% as GAAP loss widens
Genius Sports’ fiscal Q2 2026 revenue rose 64.7% to $195.5 million, helped by Betting growth and the addition of Legend to Media. Adjusted EBITDA increased 54% to $52.6 million, but the GAAP net loss widened to $76.7 million as acquisition-related costs, new interest expense, contingent consideration remeasurement and a less favorable currency comparison weighed on results. The company raised full-year revenue and adjusted EBITDA guidance, while investors now need to assess Legend integration, the gap between adjusted earnings and cash flow, and prediction-market execution.
TradingKey
Thu, Aug 6
Optimum Q2 2026 earnings: Margins improved as cash flow weakened
Optimum’s Q2 2026 revenue fell 5.8% year over year to $2.02 billion, while its GAAP diluted loss widened to $0.67 per share from $0.21. Adjusted EBITDA declined 2.2% to $785.7 million, but margin expanded 140 basis points to 38.8% as costs fell. Operating cash flow dropped 44.6%, producing a $91.9 million free cash flow deficit despite lower capital spending. Broadband losses totaled 40,000, while mobile added about 50,000 lines. Consolidated net debt was $25.33 billion at quarter-end.
TradingKey
Thu, Aug 6
Frontdoor Q2 2026 earnings: Lower claims costs helped profits outpace revenue
Frontdoor’s Q2 2026 revenue rose 5% year over year to $645 million, while diluted EPS increased 19% to $1.76 and adjusted EBITDA climbed 10% to $220 million. Higher realized pricing, modest volume growth, and lower contract claims costs—including a $5 million favorable-weather benefit—helped profits grow faster than sales. Ending home warranty membership reached 2.11 million, up 1%. Six-month operating cash flow was $245 million and free cash flow was $233 million. Frontdoor raised its 2026 revenue and adjusted EBITDA outlook.
TradingKey
Thu, Aug 6
CPI Q2 2026 Earnings: Secure Card Growth Lifts Revenue 15%
CPI Card Group’s Q2 2026 revenue rose 15% to $149.2 million, while net income increased 294% to $2.0 million and adjusted EBITDA grew 7% to $24.1 million. Secure Card Solutions led the quarter, helped by contactless card and personalization demand, Arroweye, and more than $3 million of tariff refunds. CPI raised its 2026 revenue growth outlook to high-single-digit to low-double-digit growth and lifted free cash flow guidance to $45 million-$50 million, while keeping adjusted EBITDA growth guidance unchanged amid Integrated Paytech investment and uneven higher-margin Prepaid demand.
TradingKey
Thu, Aug 6
BKV Q2 2026 earnings: Upstream growth lifts adjusted EBITDAX
BKV Corporation’s Q2 2026 earnings showed a split between reported and underlying performance. Net income attributable to BKV fell to $75.8 million from $107.8 million, while adjusted EBITDAX rose to $142.0 million and operating cash flow increased to $109.7 million. Upstream production climbed about 21% to 978.3 MMcfe/d and lower operating cash costs supported results, but weaker wholesale power prices reduced Power revenue and operating income despite higher generation. Updated 2026 guidance calls for 940–960 MMcfe/d of production and $690–$875 million of total capital expenditures.
TradingKey
Thu, Aug 6
Versant Q2 2026 earnings: Linear decline outweighs platform growth
Versant Media’s (Nasdaq: VSNT) Q2 2026 revenue fell 3.8% to $1.64 billion, while diluted EPS declined to $1.49 from $2.09. Net income attributable to Versant dropped 30.1% to $211 million as lower revenue, public-company costs, post-separation interest expense and higher taxes outweighed platform growth and cost savings. Platforms revenue rose 9.3% excluding SportsEngine, but linear distribution revenue fell 6.3%. The company raised its full-year revenue and adjusted EBITDA outlook while maintaining free cash flow guidance at $1.0 billion to $1.2 billion.TradingKey
Thu, Aug 6
Zoetis Q2 2026 earnings: U.S. companion animal weakness offsets global growth
Zoetis reported Q2 2026 revenue of $2.468 billion, essentially flat year over year and down 1% organically, while GAAP net income fell 5% to $691 million. Diluted EPS rose 1% to $1.65 as the share count declined, and adjusted EPS increased 5% to $1.87 despite lower adjusted net income. U.S. segment revenue dropped 7% amid weaker companion animal demand, partly offset by 8% reported international growth and 23% U.S. livestock growth. Zoetis revised full-year guidance to revenue of $9.120-$9.320 billion and adjusted EPS of $6.15-$6.25.
TradingKey
Thu, Aug 6
Featured Tools
Top News
Meta Q3 Net Profit Surges 264% YoY, Raises Full-Year Capex Slightly; Shares Briefly Rise Over 4% After Hours
US Stocks Close: Nasdaq Gains Over 1%, Philadelphia Semiconductor Index Rises Nearly 2%; Tech Stocks Strengthen, SpaceX Gains Nearly 8% Post-Earnings
Tesla Q3 Operating Profit Plunges 56% YoY, Dragged Down by Higher Operating Expenses Including R&D
Meta Q3 2026 Earnings: Legal Charge Halves Operating Margin Despite 26% Revenue Growth
US Stocks Close: Nasdaq Drops 2.6%, SOX Falls Over 6%; Jensen Huang's Remarks on Capital Shortage Spark Financing Concerns, Meta Drops 7% After Earnings
